Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00383994
Status:
COMPLETED
Last Update Posted:
2019-07-31
First Post:
2006-10-02
Brief Title:
Immunotherapy With NK Cell Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Disorder Related to Transplantation |
| Lymphoma |
| Leukemia |
| Transplantation Stem Cell |
| Lymphoid Malignancies |
Keywords:
| Name | View |
|---|---|
| Chronic Lymphocytic Leukemia | View |
| CLL | View |
| Non-Hodgkins Lymphoma | View |
| B-Cell Lymphoma | View |
| Lymphoma | View |
| granulocyte-macrophage colony-stimulating factor | View |
| Leukemia | View |
| NK Cells | View |
| Rituximab | View |
| GM-CSF | View |
| Non-myeloablative Allogeneic Stem Cell Transplantation | View |
| Stem Cell Transplant | View |